Search

Pulse Biosciences Inc

Geschlossen

BrancheGesundheitswesen

43.42 -2.12

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

42.34

Max

44.36

Schlüsselkennzahlen

By Trading Economics

Einkommen

-6.1M

-25M

Verkäufe

33K

434K

EPS

-0.36

Gewinnspanne

-5,681.336

Angestellte

116

EBITDA

-5.8M

-25M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

-7.66% downside

Dividenden

By Acuity

Nächstes Ergebnis

4. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

349M

3B

Vorheriger Eröffnungskurs

45.54

Vorheriger Schlusskurs

43.42

Pulse Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

12. Aug. 2026, 20:06 UTC

Pulse Biosciences Inc. shares are lower today, continuing a decline after an early peak. The asset remains above its 20-day moving average.

11. Aug. 2026, 23:01 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reversing earlier gains despite being above its 20-day moving average. No specific news was identified.

10. Aug. 2026, 21:01 UTC

Pulse Biosciences Inc shares are lower in after-market hours, reflecting no specific news to explain the movement. The asset remains above its 20-day moving average.

7. Aug. 2026, 19:51 UTC

News

Pulse Biosciences shares are higher after reporting second-quarter revenue of $434,000 and increasing patient enrollment targets for its pivotal trial.

6. Aug. 2026, 22:16 UTC

News

Pulse Biosciences reported a net loss of $24.7 million for Q2 2026. Shares are trading higher after announcing significant progress in its cardiac catheter program.

5. Aug. 2026, 20:06 UTC

Pulse Biosciences Inc shares are lower during Wednesday's trading session, reversing from a recent trend of higher daily closes. No specific news was identified.

3. Aug. 2026, 20:03 UTC

Pulse Biosciences Inc shares are higher today, driven by a significant advance in the Health Care Equipment sector and unusually high trading volume.

31. Juli 2026, 19:16 UTC

Pulse Biosciences Inc is gaining during Friday's session, reaching a high above Thursday's close. The stock remains above its 20-day moving average.

30. Juli 2026, 20:09 UTC

Event

Pulse Biosciences' NANOPULSE-AF Study enrollment surpasses midpoint, supporting stock gains since Wednesday. Shares remain above the 20-day moving average amid market volatility.

29. Juli 2026, 22:03 UTC

Event

Pulse Biosciences shares are lower in after-market hours despite surpassing enrollment midpoint in its NANOPULSE-AF Study, reflecting broader cautious market sentiment.

28. Juli 2026, 23:46 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reflecting volatility amid broader market declines, though no specific news was identified.

27. Juli 2026, 19:51 UTC

Pulse Biosciences Inc shares are higher today amid unusually high trading volume, despite earlier downward movement. No specific news was identified to explain the move.

24. Juli 2026, 18:11 UTC

Pulse Biosciences Inc shares are lower today, breaking a trend of higher daily closes. The stock is trading with unusually high market volume.

22. Juli 2026, 19:31 UTC

Pulse Biosciences shares are higher today amid increased trading volume, despite earlier pulling back from session highs. No specific news was identified to explain the movement.

21. Juli 2026, 22:51 UTC

Pulse Biosciences Inc shares declined in after-market trading, reversing earlier gains. No specific news was identified to explain the price movement.

20. Juli 2026, 19:26 UTC

Shares of Pulse Biosciences Inc. are lower today, reversing earlier gains amid broader market pressure from rising US Treasury yields and geopolitical uncertainties.

Peer-Vergleich

Kursveränderung

Pulse Biosciences Inc Prognose

Kursziel

By TipRanks

-7.66% Nachteil

12-Monats-Prognose

Durchschnitt 41 USD  -7.66%

Hoch 45 USD

Tief 35 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pulse Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat